Attributes | Values |
---|
rdf:type
| |
Description
| - This prospective clinical study evaluated the pharmacokinetics (PK) (compared to IMMUNATE (R)), efficacy and safety of IMMUNATE S/D in 56 previously treated patients with severe hemophilia
- This prospective clinical study evaluated the pharmacokinetics (PK) (compared to IMMUNATE (R)), efficacy and safety of IMMUNATE S/D in 56 previously treated patients with severe hemophilia (en)
- Farmakokinetika, účinnost a bezpečnost IMMUNATE solvent/detergent (IMMUNATE S/D) u dříve léčených pacientů s těžkou formou hemofilie A: výsledky prospektivní, multicentrické, otevřené fáze III studie. (cs)
|
Title
| - Pharmacokinetics, efficacy and safety of IMMUNATE (R) Solvent/Detergent (IMMUNATE (R) S/D) in previously treated patients with severe hemophilia A: Results of a prospective, multicenter, open-label phase III study
- Pharmacokinetics, efficacy and safety of IMMUNATE (R) Solvent/Detergent (IMMUNATE (R) S/D) in previously treated patients with severe hemophilia A: Results of a prospective, multicenter, open-label phase III study (en)
- Farmakokinetika, účinnost a bezpečnost IMMUNATE solvent/detergent (IMMUNATE S/D) u dříve léčených pacientů s těžkou formou hemofilie A: výsledky prospektivní, multicentrické, otevřené fáze III studie (cs)
|
skos:prefLabel
| - Pharmacokinetics, efficacy and safety of IMMUNATE (R) Solvent/Detergent (IMMUNATE (R) S/D) in previously treated patients with severe hemophilia A: Results of a prospective, multicenter, open-label phase III study
- Pharmacokinetics, efficacy and safety of IMMUNATE (R) Solvent/Detergent (IMMUNATE (R) S/D) in previously treated patients with severe hemophilia A: Results of a prospective, multicenter, open-label phase III study (en)
- Farmakokinetika, účinnost a bezpečnost IMMUNATE solvent/detergent (IMMUNATE S/D) u dříve léčených pacientů s těžkou formou hemofilie A: výsledky prospektivní, multicentrické, otevřené fáze III studie (cs)
|
skos:notation
| - RIV/00064203:_____/08:4023!RIV09-MZ0-00064203
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00064203:_____/08:4023
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - hemophilia A; factor VIII; von Willebrand factor; IMMUNATE (R) S/D; von-willebrand-disease; factor-viii concentrate; recombinant factor-viii; prophylactic treatment; nijmegen modification; solvent detergent; viral-infection; bethesda assay; c inhibitors; low-risk (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - CH - Švýcarská konfederace
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| |
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |